Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

23.39
+1.125.05%
Volume:2K
Turnover:36.10K
Market Cap:4.68M
PE:- -
High:23.40
Open:23.08
Low:23.01
Close:22.27
52wk High:24.20
52wk Low:14.71
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.39
T/O Rate:0.78%
Dividend:0.77
Dividend Rate:3.30%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Berenberg Upgrades Eli Lilly and Co. to Buy From Hold, Adjusts Price Target to $1,400 From $1,220

MT Newswires Live
·
Sep 15

Lilly Gains After Berenberg Upgrades to 'buy' on Obesity Pill Momentum

Reuters
·
Sep 15

Eli Lilly : Berenberg Raises to Buy from Hold; Raises Target Price to $1,400 from $1,220

THOMSON REUTERS
·
Sep 15

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 15

Bio-Techne Supplements Merger Proxy Amid Shareholder Litigation

TIPRANKS
·
Sep 15

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
Sep 15

Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million

Reuters
·
Sep 15

Eli Lilly Stock (LLY) Has 45% Upside, Says Citigroup

TIPRANKS
·
Sep 15

Novo Nordisk is Dropping Some Weight. it Still Faces a Bigger Challenge.

Dow Jones
·
Sep 15

Eli Lilly Exec Says Co NOW Has More than 30% Share in New Starts Within Oral Obesity Treatment Market -Morgan Stanley Conf

THOMSON REUTERS
·
Sep 15

Eli Lilly and Co Stock (LLY) Moved Up by 3.01% on Sep 14: Drivers Behind the Movement

TradingKey
·
Sep 15

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Sep 14

Eli Lilly Announces R$ 0.2 Per Unit Dividend for 3Q 2026 BDRs

Reuters
·
Sep 14

One State's Battle to Stop People from Taking Unapproved Weight-Loss Drugs

Dow Jones
·
Sep 14

Cellectis pivots to in vivo gene editing and exits key CAR-T programs

TIPRANKS
·
Sep 14

Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company

GlobeNewswire
·
Sep 14

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Dow Jones
·
Sep 12

Sector Update: Healthcare Stocks Ease in Afternoon Trading

MT Newswires Live
·
Sep 12

Moderna Inc Stock (MRNA) Moved Up by 8.63% on Sep 11: A Full Analysis

TradingKey
·
Sep 12